4.4 Article

A simple, robust, and affordable bioluminescent assay for drug discovery against infective African trypanosomes

Journal

DRUG DEVELOPMENT RESEARCH
Volume 83, Issue 2, Pages 253-263

Publisher

WILEY
DOI: 10.1002/ddr.21634

Keywords

African trypanosomiasis; high-throughput screening; luciferase; Trypanosoma brucei; genetically encoded biosensor

Funding

  1. Comision Academica de Posgrado (Universidad de la Republica, Uruguay)
  2. Institut Pasteur de Montevideo [06-16]

Ask authors/readers for more resources

African trypanosomiasis is a major health problem in endemic countries and requires new drugs for treatment. In this study, a simple and economical high-throughput screening assay was developed using a bioluminescent cell line of the trypanosome parasite. The assay showed high sensitivity and accuracy in identifying compounds with potent anti-parasitic activity.
African trypanosomiasis is a major problem for human and animal health in endemic countries, where it threatens millions of people and affects economic development. New drugs are needed to overcome the toxicity, administration, low efficacy, and resistance issues of the current chemotherapy. Robust, simple, and economical high-throughput, whole-cell-based assays are required to accelerate the identification of novel chemical entities. With this aim, we generated a bioluminescent cell line of the bloodstream stage of Trypanosoma brucei brucei and established a screening assay. Trypanosomes were stably transfected to constitutively express a thermostable red-shifted luciferase. The growth phenotype and drug sensitivity of the reporter cell line were essentially identical to that of the parental cell line. The endogenous luciferase activity, measured by a simple bioluminescence assay, proved to be proportional to parasite number and metabolic status. The assay, optimized to detect highly potent compounds in a 96-well-plate format, was validated by screening a small compound library (inter-assay values for Z' factor and coefficient variation were 0.77 and 5.8%, respectively). With a hit-confirmation ratio of similar to 97%, the assay was potent enough to identify several hits with EC50 <= 10 mu M. Preliminary tests indicated that the assay can be scaled up to a 384-well-plate format without compromising its robustness. In summary, we have generated reporter trypanosomes and a simple, robust, and affordable bioluminescence screening assay with great potential to speed up the early-phase drug discovery against African trypanosomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available